The first two cases of transcatheter mitral valve repair with ARTO system in Asia
10.5847/wjem.j.192-8642.2020.01.005
- Author:
Kai-da Ren
;
Zhao-xia Pu
;
Lei Yu
;
Feng Gao
;
Li-han Wang
;
Stella Ng
;
Ju-bo Jiang
;
Hua-jun Li
;
Yong Xu
;
Wei He
;
Min Yan
;
Xian-bao Liu
;
Jian-an Wang
- Publication Type:Journal Article
- Keywords:
Mitral regurgitation;
Mitral valve repair;
ARTO system
- From:
World Journal of Emergency Medicine
2020;11(1):33-36
- CountryChina
- Language:English
-
Abstract:
BACKGROUND:MAVERIC (Mitral Valve Repair Clinical Trial) validates the safety and efficacy of the ARTO system. We here report the first two successful cases of utilizing the ARTO system in patients with symptomatic heart failure (HF) with functional mitral regurgitation (FMR) in Asia.
METHODS:Two patients, aged 70 and 63, had severe HF with FMR. Transesophageal echocardiography confirmed that the left ventricular ejection fractions were less than 50% with severe mitral regurgitation (MR) in both patients. Optimizing drug treatment could not mitigate their symptoms. Therefore, we used the ARTO system to repair the mitral valve for these patients on March 5 and 6, 2019, respectively.
RESULTS:Mitral valve repairs using the ARTO system were successfully performed under general anaesthesia for these two patients. MR was decreased immediately after the procedures in both patients. The 30-day and 3-month transthoracic echocardiography (TTE) revealed a moderate to severe MR in both patients, and the New York Heart Association (NYHA) scales were also partially improved.
CONCLUSION:The first two cases in Asia indicate that the ARTO system is feasible for patients with heart failure with FMR, and the patient selection appears to be crucial.
- Full text:005 ARTO revised.pdf
